Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients

Affiliations

• ¹ Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium.
• ² Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000 Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
• ³ Scientific Directorate Infectious Diseases in Humans, Sciensano, Brussels, Belgium.
• ⁴ Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
• ⁵ Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000 Antwerp, Belgium.
• ⁶ Department of medicine, division of Hematology, CHU of Liège, Liège, Belgium.
• ⁷ Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium; Department of medicine, division of Hematology, CHU of Liège, Liège, Belgium.
• ⁸ Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium.
• ⁹ Department of Biostatistics, University Hospital of Liège, Liège, Belgium.
• ¹⁰ Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium; Department of medicine, division of Hematology, CHU of Liège, Liège, Belgium. Electronic address: f.baron@uliege.be.